Retrospective Analysis of the Potential Effects of CH[A.sub.2]D[S.sub.2]-VASc and HAS-BLED Scores on Treatment Choices for Atrial Fibrillation Patients in a Stroke Center/Bir Inme Merkezinde Atrial Fibrilasyon Hastalarinin Tedavi Secimlerinde CH[A.sub.2]D[S.sub.2]-VASc ve HAS-BLED Skorlarinin Potansiyel Etkilerinin Geriye Donuk Analizi

Objectives: Current information lacks an algorithm that directs us to a specific anticoagulation treatment option for patients with atrial fibrillation (AF), except in certain situations. Our aim was to evaluate the potential relationship between different oral anticoagulant choices and the CH[A.sub...

Full description

Saved in:
Bibliographic Details
Published in:Boğaziçi tıp dergisi 2024-03, Vol.11 (1), p.1
Main Authors: Aslan, Isil Kalyoncu, Erkalayci, Ceren, Ramazanoglu, Leyla, Keskin, Kadriye Guleda
Format: Article
Language:Turkish
Subjects:
Algorithms
Analysis
Apixaban
Atrial fibrillation
Care and treatment
Drug therapy
Heart failure
Hypertension
Liver
Patient compliance
Stroke (Disease)
Substance abuse
Warfarin
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: Current information lacks an algorithm that directs us to a specific anticoagulation treatment option for patients with atrial fibrillation (AF), except in certain situations. Our aim was to evaluate the potential relationship between different oral anticoagulant choices and the CH[A.sub.2]D[S.sub.2]-VASc (congestive heart failure, hypertension, age, diabetes mellitus, stroke, vascular disease, age, sex category) and HAS-BLED (hypertension, abnormal renal and liver function, stroke, bleeding, labile international normalized ratio (INR), elderly, drugs or alcohol) scores of patients, and their treatment compliance. Methods: We retrospectively documented the patients' age, gender, CH[A.sub.2]D[S.sub.2]-VASc, and HAS-BLED scores to assess our preference for oral anticoagulants in AF patients. Two hundred patients with AF were divided into two main groups: those with newly diagnosed AF and those with an established diagnosis of AF. The treatment compliance of patients with AF was documented, and the treatment choices at discharge for patients in both groups were compared based on age, gender, and the two scores. Scores were divided into three main groups for easy comparison. The level of statistical significance was accepted as p
ISSN:2149-0287
2149-0287
DOI:10.14744/bmj.2024.12599